亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Long-term postoperative outcomes in patients with hilar cholangiocarcinoma: a single-center experience

医学 切除术 外科 存活率 普通外科 切除缘 生存分析 回顾性队列研究 并发症 阶段(地层学)
作者
Yu. A. Kovalenko,A. D. Makarchev,O.Ya. Muhtarov,T. V. Shevchenko,Vladimir Semenovich Ruzavin,Beslan Nuralievich Gurmikov
出处
期刊:Хирургия [Meditsina]
卷期号: (3): 18-18
标识
DOI:10.17116/hirurgia202603118
摘要

Objective. To evaluate long-term postoperative outcomes in patients with hilar cholangiocarcinoma. Material and methods. This study included patients with hilar cholangiocarcinoma who underwent primary surgery at the Vishnevsky National Research Center of Surgery. Exclusion criteria: surgery outside our hospital, death within 90 days after surgery, distant metastases and combined hepatocellular carcinoma. Extent of surgery was determined by modern guidelines. Comparison groups included patients with different resection statuses. Statistical analysis was performed using STATISTICA 13 software. Results. The study included 92 patients (60 men (65.2%) and 32 women (34.8%)). Age ranged was from 18 to 83 years. Patients underwent resection of the common bile duct (13 (14.1%) cases), hemihepatectomy with bile duct resection (55 (59.8%) cases); extended hemihepatectomy with bile duct resection (16 (17.4%) cases), resection of extrahepatic bile ducts combined with PDE (1 (1.1%) case). In 32 (38.5%) cases, regional lymph node involvement was noted. We assessed all loci of tumor invasion in longitudinal and radial resection margins, as well as excised regional lymph nodes. According to our classification, resection status was as follows depending on the number of R+ loci and lymph node assessment: R0 — 7 (8.75%), R+1 — 2 (2.5%), R+2 — 7 (8.75%), R+3 — 3 (3.75%), R+4 — 6 (7.5%), R+5 — 14 (17.5%), R+6 — 21 (25.25%), R+7 — 20 (25%), respectively. According to multivariate analysis, significant factors of unfavorable prognosis were TNM stage (p=0.006), tumor cells in lymph nodes (p=0.01), differentiation grade (p=0.02) and perineural invasion (p=0.03). Overall 1-, 3-, 5-, 7- and 10-year survival rates were 70%, 30%, 18%, 16%, and 16%, respectively. Survival significantly differed between R0 and R+1—7 resection groups (p=0.01). Conclusion. Resection of extrahepatic bile ducts is radical for Bismuth-Corlette types I-II. Extensive liver resections are indicated for types III-IV. To assess resection quality, it is important to consider “clearness” of true resection margin, taking into account all loci of invasion. According to this approach, 5-year survival rate after R0 or R+1—2 resection is 100%.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
纯情的阁发布了新的文献求助10
1秒前
2秒前
纯情的阁发布了新的文献求助10
3秒前
纯情的阁发布了新的文献求助10
3秒前
纯情的阁发布了新的文献求助10
3秒前
纯情的阁发布了新的文献求助10
3秒前
纯情的阁发布了新的文献求助10
3秒前
纯情的阁发布了新的文献求助100
7秒前
纯情的阁发布了新的文献求助10
7秒前
纯情的阁发布了新的文献求助10
7秒前
h11的应助被纯情的阁采纳,获得30
13秒前
快乐的稚晴完成签到,获得积分10
18秒前
22秒前
曾经的盼望完成签到,获得积分10
27秒前
totoro完成签到 ,获得积分10
27秒前
so完成签到 ,获得积分10
47秒前
null的应助被纯情的阁采纳,获得10
53秒前
evans完成签到,获得积分10
54秒前
淡然海完成签到,获得积分10
54秒前
李爱国的应助被Kevin采纳,获得30
1分钟前
激动的烙完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
孤独怀寒完成签到,获得积分10
1分钟前
舒服的芝麻完成签到,获得积分10
1分钟前
咚咚完成签到,获得积分10
1分钟前
2分钟前
木齐Jay完成签到,获得积分10
2分钟前
Hello的应助被落润晓采纳,获得10
2分钟前
开朗的翠霜完成签到,获得积分10
2分钟前
2分钟前
zhanghao完成签到,获得积分10
2分钟前
落寞的姿完成签到,获得积分10
2分钟前
香蕉觅云的应助被纯情的阁采纳,获得10
2分钟前
称心忆灵完成签到,获得积分10
2分钟前
2分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
2分钟前
科研通AI6.4的应助被纯情的阁采纳,获得10
2分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158751
求助须知:如何正确求助?哪些是违规求助? 9554476
关于积分的说明 21719285
捐赠科研通 7748357
什么是DOI,文献DOI怎么找? 3427080
关于科研通互助平台的介绍 2551971
邀请新用户注册赠送积分活动 2471339